Alexander Nolte

Chief Accounting Officer, Syndax Pharmaceuticals Inc.

Companies

Oncorus, Inc.Chief financial officer May 22, 2023 to May 22, 2023¹
Syndax Pharmaceuticals IncChief Accounting Officer Nov 4, 2021 to Feb 3, 2023²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Syndax Pharmaceuticals Inc SNDX0 shares³Feb 1, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Feb 1, 2022Sold 968 shares at $16.65 of Syndax Pharmaceuticals Inc³
Jan 31, 2022Other 968 shares at $12.39 of Syndax Pharmaceuticals Inc³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGAROncorus, Inc., Chief financial officer
2
SEC EDGARSyndax Pharmaceuticals Inc, Chief Accounting Officer
3
SEC EDGARSyndax Pharmaceuticals Inc shares after the filing of Feb 1, 2022